Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Asset Writedowns and Impairment (2016 - 2024)

Historic Asset Writedowns and Impairment for Bruker (BRKRP) over the last 12 years, with Q4 2024 value amounting to $1.0 million.

  • Bruker's Asset Writedowns and Impairment fell 6296.3% to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $22.6 million, marking a year-over-year increase of 761.9%. This contributed to the annual value of $28.5 million for FY2024, which is 2837.84% up from last year.
  • Bruker's Asset Writedowns and Impairment amounted to $1.0 million in Q4 2024, which was down 6296.3% from $20.2 million recorded in Q2 2024.
  • In the past 5 years, Bruker's Asset Writedowns and Impairment ranged from a high of $20.2 million in Q2 2024 and a low of -$1.9 million during Q3 2022
  • Over the past 3 years, Bruker's median Asset Writedowns and Impairment value was $1.8 million (recorded in 2022), while the average stood at $4.5 million.
  • As far as peak fluctuations go, Bruker's Asset Writedowns and Impairment skyrocketed by 1150000.0% in 2023, and later crashed by 7971.01% in 2024.
  • Bruker's Asset Writedowns and Impairment (Quarter) stood at $1.6 million in 2022, then surged by 68.75% to $2.7 million in 2023, then crashed by 62.96% to $1.0 million in 2024.
  • Its Asset Writedowns and Impairment stands at $1.0 million for Q4 2024, versus $20.2 million for Q2 2024 and $1.4 million for Q1 2024.